市場調查報告書
商品編碼
1495974
全球醫療廢棄物管理市場-2024年至2029年預測Global Medical Waste Management Market - Forecasts from 2024 to 2029 |
醫療廢棄物管理市場預計將從 2022 年的 172.09 億美元增至 2029 年的 255.62 億美元,預測期內複合年成長率為 5.87%。
醫療廢棄物是由於醫療機構中執行的醫療、手術和處理程序而產生的。醫院、診斷機構和診所產生的廢棄物必須妥善處理和管理。醫療廢棄物管理是指透過焚燒、化學處理和高壓釜等各種服務來收集、處理和處置生物醫療廢棄物。
醫療廢棄物管理確保生物醫學廢棄物得到收集、控制、處理和妥善處置,以保護公眾、動物和環境。市場區隔是按廢棄物類型、處理地點、服務和區域進行的。
大部分的醫療廢棄物是由於各種疾病的處理和檢測而產生。醫療活動產生的廢棄物中約 85% 是無害的。同樣,約 15% 的廢棄物具有危險、有毒和傳染性,構成嚴重的健康風險。據世界衛生組織稱,2018 年全球注射次數超過 160 億次,因此需要對醫療廢棄物進行適當和充分的處置以安全處置。因此,隨著對安全注射處理以避免健康危機的需求增加,醫療廢棄物管理市場預計將會成長。
由於 COVID-19 大流行,醫院正在排放更多無害醫療廢棄物,例如一次性濕紙巾和空消毒劑容器,推動醫療廢棄物管理行業向前發展。此外,職業安全與健康管理局 (OSHA) 和緝毒局 (DEA) 等聯邦機構對 COVID-19 醫療廢棄物製定了具體的處置標準。這些指南簡化並改善了醫療廢棄物管理流程,從而提高了醫療廢棄物管理的接受度。據中央污染控制委員會稱,2020 年 6 月至 2021 年 5 月期間,由於診斷活動和處理 COVID-19 患者的增加,印度產生了 45,308 噸生物醫學廢棄物。
此外,政府改善醫療廢棄物管理的努力正在推動市場向前發展。例如,美國環保署於 2019 年簽署了一項名為「危險廢棄物藥品廢棄物管理標準和尼古丁 P075 清單修正案」的規則,概述了簡化危險藥品廢棄物處置的規則。此外,研究活動資金的增加以及生物醫學產品和技術的普及正在推動市場擴張。例如,2021年5月,印度喜馬偕爾邦批准了一個新的通用生物醫學廢棄物處理和處置設施,以減輕焚燒生物醫學廢棄物產生的醫療廢棄物的負擔,並宣布計劃將容量從2.4噸(MT )增加到6.4噸。同樣,中國政府和聯合國開發計畫署(UNDP)於2021年8月在尼泊爾宣布了一項新舉措,幫助這個南亞國家的七家醫院改善醫療廢棄物管理系統,並幫助新興國家更好地應對這一流行病。
預計北美將在預測期內推動醫療廢棄物管理市場的成長。
由於慢性病盛行率不斷上升,大公司的入駐提高了廢棄物管理的環保意識,導致該地區醫療廢棄物量增加。預計北美將佔據醫療廢棄物管理市場的很大一部分。在美國,許多醫院已經開始回收一次性產品,然後以低價賣給醫院。
該地區的許多公司正在尋求各種成長途徑,包括合作夥伴關係、協議、併購和收購,以增加其在市場上的影響力。例如,美國廢棄物管理、綜合廢棄物管理和環境服務公司Waste Management, Inc.在2019年斥資46億美元收購了Advanced Disposal Services, Inc.。此次收購擴大了 Waste Management 的業務範圍,並為美國 16 個州的超過 300 萬新商業、工業和住宅客戶提供無與倫比的差異化永續廢棄物管理和回收服務。
The global medical waste management market is projected to grow at a CAGR of 5.87% during the forecast period to reach US$25.562 billion by 2029, up from US$17.209 billion in 2022.
Medical waste is generated as a result of medical, surgical, and therapeutic procedures carried out in healthcare institutions. Hospitals, diagnostic institutes, and clinics generate waste that must be properly handled and managed. Medical waste management is defined as the collection, treatment, and disposal of biomedical waste through various services, such as incineration, chemical treatment, and autoclaving.
Medical waste management assures that biomedical waste is collected, contained, processed, and properly disposed of, safeguarding the general public, animals, and the environment. The global medical waste management market is segmented by waste type, treatment site, service, and geography.
The majority of medical waste is generated as a result of various disease treatments and tests. Approximately 85% of waste generated by healthcare activities is non-hazardous. Similarly, around 15% of waste is hazardous, meaning it is toxic and infectious, posing a serious health risk. According to the WHO, over 16 billion injections were administered worldwide in 2018, necessitating proper and adequate processing to dispose of medical waste safely. As a result, the medical waste management market is expected to grow as the demand for safe injection disposal grows to avert health crises.
As a result of the COVID-19 outbreak, hospitals are producing more non-hazardous medical waste, such as disposable wipes and empty disinfection containers, propelling the medical waste management industry forward. Furthermore, federal agencies such as the Occupational Safety and Health Administration (OSHA) and the Drug Enforcement Administration (DEA) have specific disposal standards for COVID-19 medical waste. These guidelines simplify and improve the medical waste management process, resulting in increased acceptance of medical waste management. According to the Central Pollution Control Board, India generated 45,308 tons of biomedical waste between June 2020 and May 2021 as a result of an increase in the number of diagnostic activities and treatment of COVID-19 patients.
Furthermore, government attempts to improve the management of medical waste are propelling the market ahead. The US Environmental Protection Agency, for example, signed a rule in 2019 titled "Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 listing for Nicotine", which outlines streamlined rules for treating hazardous pharmaceutical waste. Furthermore, increased funding for research activities and the widespread use of biomedical products and technologies are driving market expansion. For instance, to reduce the burden of medical waste generated, the Indian state of Himachal Pradesh announced plans in May 2021 to increase the volume of bio-medical waste incineration from 2.4 metric tonnes (MT) per day to 6.4 MT per day by authorizing a new common bio-medical waste treatment and disposal facility. Similarly, the Chinese government and the United Nations Development Program (UNDP) announced a new effort in Nepal in August 2021 to assist seven hospitals in the South Asian country in improving their healthcare waste management systems to better address the COVID-19 pandemic.
North America is expected to drive the global medical waste management market growth during the forecast period.
Because of the rising incidence of chronic diseases, the presence of major players has increased environmental consciousness regarding waste management and led to an increase in the amount of medical waste in the region. North America is likely to hold a significant proportion of the medical waste management market. In the United States, many hospitals have started recycling single-use products, which are subsequently sold back to the hospitals at a reduced price.
Many companies in the region are pursuing various growth methods such as collaborations, agreements, mergers, and acquisitions to strengthen their market presence. For example, Waste Management, Inc., a US-based waste management, comprehensive waste management, and environmental services firm, paid $4.6 billion for Advanced Disposal Services, Inc. in 2019. The acquisition expands Waste Management's presence and allows the firm to provide an unrivaled level of differentiated, sustainable waste management and recycling services to over 3 million new commercial, industrial, and residential customers in 16 states throughout the US.